 |
NorLeu3-Angiotensin(1-7) [NorLeu3-A(1-7)] |
|---|---|
| Trade Name | |
| Orphan Indication | Dermal injury due to nuclear/radiation incident |
| USA Market Approval | USA |
| USA Designation Date | 2014-01-31 00:00:00 |
| Sponsor | US Biotest, Inc.;231 Bonetti Dr.,, Suite 240;San Luis Obispo, California, 93401 |
